MAB Registration Exam

It tests applied medical affairs judgment across ten domains, from drug development and regulatory compliance to pharmacovigilance, health economics, and publication planning. Items are multiple choice and often scenario-based, so you must choose the most appropriate professional action, not just define a term.

It suits MSLs, medical information and medical communications professionals, medical advisors, and colleagues in regulatory, safety, or market access who interface with medical affairs. Early-career candidates use it to structure their learning; experienced professionals use it to confirm breadth across domains they do not handle daily.

The administering body sets the current question count, time limit, and appointment structure, and these can change between testing windows. Check the official MAB website or your registration confirmation for the authoritative figures rather than relying on secondhand reports from earlier sittings.

Passing standards and fees are published by the administering organization and are not fixed across cycles. Confirm the current passing score, fee schedule, and any membership or early-registration discounts directly on the official site before you budget or book a test date.

Most candidates find the breadth harder than any single item. Common failure modes are shallow coverage of pharmacovigilance and health economics, confusing promotional and non-promotional exchange rules, and answering from habit rather than the scenario. Read each stem fully and eliminate options that breach compliance.

Retake rules, waiting periods, and any attempt limits are set by the administering body and are not universal. Review its current policy on the official site, and use the score report to identify weak domains before reapplying so a second attempt is targeted rather than a repeat.

Start with fundamentals and the drug development and clinical research domains, since later material assumes them. Then take regulatory compliance, medical information, and field medical together, followed by evidence generation, pharmacovigilance, and health economics. Finish with ethics and publication planning, which draw on everything before them.

Allow enough weeks to cover all ten domains at least once and revisit your weakest two. Weight study time roughly by domain emphasis, but do not skip low-weight domains entirely, since a handful of missed items in health economics or publication planning can decide a borderline result.

No. It signals structured knowledge of medical affairs practice; it does not license you to practice, replace an advanced scientific degree, or substitute for employer SOP training and local legal requirements. Treat it as complementary evidence of competence alongside your experience.

Anchor on patient safety and scientific accuracy first, then on the applicable code or regulation, then on the commercial relationship. Options that promise, imply, or speculate beyond approved data are usually wrong. If an adverse event surfaces in a scenario, the correct action typically includes prompt safety reporting.